Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

. He can be reached at nsaraceno@mjhlifesciences.com.

Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, outlines the key provisions of the recently released executive order on healthcare price transparency.

Breaking Down the New Executive Order on Healthcare Price Transparency

Articles

The latest news for pharma industry insiders.

Pharma Pulse 4/9/25: Effectively Cutting Through the Misinformation Noise, Addressing Drug Shortages & more

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product pipelines.

LogiPharma Europe 2025: Aligning People, Process, and Technology

How data-driven insights can help pharma companies balance their revenue management and innovation strategies—including resource allocation, pricing, and market access.

Maintaining R&D Investments in the IRA Era

Director of Global Healthcare & Life Sciences Industry Strategy at Google Cloud.

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

Beyond the Hype: GenAI’s Real Impact on Life Sciences Manufacturing

The conference’s opening keynote case study shares ways to elicit change that not only results in business growth and productivity, but a boost in patient connection as well.

LogiPharma Europe 2025: An Innovative Journey

Kevin Hagan, CEO, Pan Foundation, discusses central concerns for patient assistance programs as changes to Medicare and the Inflation Reduction Act take effect. 

PAP 2025: Navigating Inflation Reduction Act Reforms Amid Uncertainty for 2025

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, lays out the ways to begin transitioning a foundation. 

PAP 2025: Creating an Independent Patient Assistance Foundation 

Pharma Pulse 4/8/25: Banks Postpone Loans as Tariffs Stoke Fears, GLP-1 and Biosimilars Trends & more

New facility is expected to serve as a global hub for accelerating the development of next-generation antibody-drug conjugates for the treatment of cancer. 

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead